NASH - Nonalcoholic Steatohepatitis Completed Phase 1 Trials for Rifampicin (DB01045)

IndicationStatusPhase
DBCOND0088313 (NASH - Nonalcoholic Steatohepatitis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03213145Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy VolunteersBasic Science